Malignancy risk in patients with giant cell arteritis: a population-based cohort study

Area of Science:

• Rheumatology
• Oncology
• Epidemiology

Background:

• Giant cell arteritis (GCA) is a large-vessel vasculitis with potential systemic implications.
• The relationship between GCA and cancer risk requires further investigation.
• Understanding cancer incidence in GCA patients is crucial for comprehensive patient management.

Purpose of the Study:

• To compare cancer incidence in a population-based cohort of GCA patients against age- and sex-matched controls.
• To assess the risk of developing any malignancy, including hematologic and solid tumors, following a GCA diagnosis.

Main Methods:

• Utilized the Rochester Epidemiology Project to identify incident GCA cases from 1950-2004.
• Selected two non-GCA referent subjects per GCA patient, matched for age, sex, and medical history length.
• Followed patients until death, last contact, or end of 2006 to determine cancer diagnosis via histopathology.

Main Results:

• The study included 204 GCA patients and 407 controls.
• Cancer developed in 46 GCA patients and 76 controls (Hazard Ratio [HR] 1.26, 95% Confidence Interval [95% CI] 0.87-1.83), with no statistically significant difference.
• No significant differences were observed in hematologic or solid malignancy rates, though colon cancer showed a trend toward higher incidence in the GCA group (P=0.07).

Conclusions:

• GCA patients are not at an increased risk of developing cancer after diagnosis.
• Cancer mortality rates were similar between GCA patients and the control group.
• The findings suggest GCA itself does not predispose individuals to a higher overall cancer burden.